361 results on '"Kalwak, Krzysztof"'
Search Results
2. Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study
3. Cytogenetic abnormalities predict survival after allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a PDWP/EBMT study
4. Stem Cell Transplantation and Cellular Immunotherapies for Pediatric AML
5. Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial
6. Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
7. Retrospective comparative analysis of two medical evacuation systems for Ukrainian patients affected by war
8. Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations
9. Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course
10. Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy - a multicentre retrospective PDWP and IEWP EBMT study
11. Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia
12. Population pharmacokinetic modeling of treosulfan and rationale for dose recommendation in children treated for conditioning prior to allogeneic hematopoietic stem cell transplantation
13. Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group
14. Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors
15. Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis
16. Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders
17. Immunophenotypic CAR-T Cells Heterogeneity of Pre- and Post-Infusion of Tisagenlecleucel in Pediatric Patients with BCP-ALL.
18. Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study
19. Successful Salvage Haploidentical Bone Marrow Transplantation in a Child With Hemophagocytic Lymphohistiocytosis, When the Previously Matched Unrelated Donor Tested Positive for SARS-CoV-2 on the Day of Stem Cells Collection
20. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement
21. Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children—the Polish Pediatric Leukemia and Lymphoma Study Group experience
22. Development of a centralised triage centre for children with cancer and blood disorders in response to the humanitarian crisis in Ukraine
23. Allogeneic HSCT for classical BCR::ABL1-negative myeloproliferative neoplasms in children: the retrospective study of the EBMT Pediatric Diseases WP
24. Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies
25. Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study
26. Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
27. Feasibility and Safety of Treosulfan, Melphalan, and Thiotepa-Based Megachemotherapy with Autologous or Allogeneic Stem Cell Transplantation in Heavily Pretreated Children with Relapsed or Refractory Neuroblastoma
28. Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study
29. Comprehensive Investigation of miRNome Identifies Novel Candidate miRNA-mRNA Interactions Implicated in T-Cell Acute Lymphoblastic Leukemia
30. Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children--the Polish Pediatric Leukemia and Lymphoma Study Group experience.
31. Priapism at Diagnosis of Pediatric Chronic Myeloid Leukemia: Data Derived from a Large Cohort of Children and Teenagers and a Narrative Review on Priapism Management
32. Second Hematopoietic Stem Cell Transplantation for Post-Transplantation Relapsed Acute Leukemia in Children: A Retrospective EBMT-PDWP Study
33. HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor
34. Stany chorobowe związane z nadmiernym gromadzeniem żelaza oraz metody oznaczania zawartości żelaza w wątrobie
35. Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey
36. Outcomes of patients undergoing allogeneic haematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia; a study on behalf of the PDWP of the EBMT
37. Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
38. Zakażenia wirusowe u dzieci po przeszczepieniu komórek krwiotwórczych: raport 2016 Polskiej Pediatrycznej Grupy ds. Zakażeń Polskiego Towarzystwa Onkologii i Hematologii Dziecięcej
39. Development of a centralised triage centre for children with cancer and blood disorders in response to the humanitarian crisis in Ukraine
40. Continuous and Differential Improvement in Worldwide Access to Hematopoietic Cell Transplantation: Notable Increase of HCT for Non-Malignant Indications and from Non-Identical Related Donors
41. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience
42. Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation
43. Zakażenia wirusowe u dzieci po przeszczepieniu komórek krwiotwórczych
44. Pharmacokinetics of treosulfan and its active monoepoxide in pediatric patients after intravenous infusion of high-dose treosulfan prior to HSCT
45. Impact of Donor and Patient CMV Serology in Children Receiving First Geno-Identical or Unrelated HSCT for Malignant Hematological Disease: An EBMT Retrospective Registry Study
46. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia, a PDWP/EBMT Study
47. Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course
48. Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy - a multicentre retrospective PDWP and IEWP EBMT study
49. Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia
50. Case report: Severe combined immunodeficiency with ligase 1 deficiency and Omenn-like manifestation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.